Wildlife and nature

Animal shelters and rescues

Theater and dance

Rivers, parks and trails

Hunger and food

Schools and learning

Housing and homelessness

Community health

Mental health

Mentoring and foster care

Legal help and rights

Jobs and money help

Atlanta

The Triangle

Everywhere

The Collective Workshop

Royal Animal Refuge

Asian Americans Advancing Justice-Atlanta

Georgia Advancing Communities Together

Atlanta Writers Club

Cobb Collaborative

Bosleys Place

Jewish Fertility Foundation

Dr. Ken Culver

Kirk Smith

Summer Farmen

Christina Weber

Nancee Pronsati

Teresa Wiant

Jeffrey Sturm

Greg Wehn

Duncan Preece

Amanda Bialack-Stewart

Debbi Martinez

Yvonne Diaz

Marc Muskavitch

Thomas Carroll

Dr. Mark Awad

Dr. Ross Camidge

Beau Bolton

Jaden Southard

John Pender

Myna Kota

Merita Carroll

Roberta Plantak

Katie Delaney

Sadia Yaakov

Programs

Events

About

Treatment options

One dinner out can make a difference! 💚 Each year, Kelly and her dad, Larry, bring friends, family, coworkers, and neighbors together for a Red Robin Dine and Donate fundraiser supporting ALK-positive cancer research. Their idea is simple: choose a date, spread the word, and bring people together for a great cause. And that's the beauty of community fundraising. There are so many ways to get involved! A dinner out. A game night. A birthday celebration. A personal fundraising page. Whatever your idea, you can turn it into an opportunity to support research and help create more treatment options for people living with ALK-positive cancer. This Lung Cancer Awareness Month, we're working toward $2 million for ALK+ cancer research through our More Research = More Dreams campaign, and we'd love for you to be part of it. 💚 Ready to get started? Explore fundraising ideas, watch Kelly and Larry's full story, and find the resources to bring your own idea to life. 👉 https://alkpositive.org/fundraise-with-alk/ #MoreResearchMoreDreams #ALKPositive #LungCancerAwarenessMonth #FundraiseForResearch @RedRobin

Honoring an extraordinary physician, researcher, and friend to the ALK-positive community. ALK Positive is proud to announce a $50,000 gift to the Ross Camidge, MD, PhD, Thoracic Oncology Endowed Program Support Fund at the University of Colorado Anschutz Medical Campus. Dr. Ross Camidge has dedicated decades to advancing lung cancer research, improving treatment options, and caring for patients around the world. His innovative thinking, compassion, and commitment to pushing the boundaries of cancer care have made a lasting impact on our community. This gift is more than a tribute. It's an investment in the future of thoracic oncology, supporting continued research, patient care, education, and the next generation of physicians and researchers. We are deeply grateful for all Dr. Camidge has done and proud to help ensure the work he has inspired continues for years to come. 🔗 Read the full announcement: https://alkpositive.org/blog/alk-positive-donates-50000-to-honor-dr-ross-camidge-and-support-the-future-of-thoracic-oncology/ #ALKPositive #LungCancerResearch #ThoracicOncology #ALKPositiveCancer

🌍 ALK Positive is headed to ESMO Congress 2026! Dr. Ken Culver and Yvonne Diaz will be in attendance October 20–27, connecting with leading physicians, researchers, and global partners to advance ALK-positive cancer research and amplify the voices of patients worldwide. 💚 Every connection is an opportunity to strengthen collaboration, accelerate research, and help bring more treatment options to people living with ALK-positive cancer. 👋 Attending ESMO? Be sure to say hello to Ken and Yvonne! We'd love to connect. #ESMO2026 #ALKPositive #LungCancerResearch #PatientAdvocacy

🧬 Could CAR T-cell therapy offer a new way to treat lung cancer? It’s already transforming treatment for some blood cancers. Now researchers are exploring whether CAR T-cell therapy could help tackle lung cancer, including cancers that develop resistance to targeted therapies. Join ALK Positive and EGFR Resisters tomorrow (Sunday, Oct 18th) for a special joint ALKtALK with Dr Kyle Concannon, thoracic oncologist and physician-scientist at the University of Colorado Anschutz Medical Campus. Dr Concannon and team are developing ACES CAR T cells, an experimental approach with potential applications across ALK, EGFR, HER2 and other oncogene-driven lung cancers. 💙 What makes this research particularly exciting? It explores whether specially engineered immune cells could offer an entirely different way to target cancer cells. We’ll discuss how the science works, where the research stands today and what needs to happen before the first clinical trial. 🎤 Plus, a live Q&A with Dr Concannon! Bring your questions and hear directly from the scientist developing this approach. 📅 Sunday, October 18 ⏰ 7 p.m. ET 🔗 Register through the link in our bio! Many patient communities. One shared goal: more treatment options for everyone. 💙 #ALKPositive #EGFR #LungCancer #CARTCellTherapy

How could we find new cancer treatments faster? ALK Positive is helping fund researchers at Beth Israel Deaconess Medical Center and Dana-Farber Cancer Institute who are tackling that question—with an approach they’re now applying to lung cancer. The team developed a faster way to identify and test treatments that help immune cells recognise and destroy cancer cells. Their first results are in lymphoma, where an experimental treatment both flags cancer cells for attack and blocks a signal that protects them. Why does this matter to our ALK community? We need more treatment options, and developing them starts with finding new ways to target cancer. This is early laboratory and animal research, not yet a treatment for ALK-positive cancer. But it shows how research supported by our community can help explore possibilities across cancer types. Read more: https://bidmc.org/news-stories/all-news-stories/news/2026/09/researchers-pioneer-faster-cancer-treatment-development

🔬 What’s next in ALK-positive cancer research? Join us Sunday, Oct. 4 at 7 PM ET for a special ALKtALK with Dr. Ken Culver exploring the research, clinical trials, and collaborations helping shape what comes next for people living with ALK-positive cancer. Dr. Culver will share updates on: • New and emerging ALK research • Clinical trials and expanding trial opportunities • A new study exploring Zepbound for lorlatinib-associated weight gain • The Global ALK Alliance and growing research collaborations We’ll also share an early preview of Lung Cancer Awareness Month and how our community can get involved this November. 💜 Whether you’re newly diagnosed, exploring future treatment options, or simply want to stay informed, bring your questions and join us live. 📅 Sunday, Oct. 4 ⏰ 7 PM ET 🔗 https://alkpositive.org/event/alktalk-oct4/ Can’t join live? The recording will be available afterward on our YouTube channel.

ALK Positive Essentials

ALKtALK

Cancer research

Living with cancer

Collective

Collections

Account

Treatment options

More collections